Abstract
Although hirsutism is a common clinical entity, treatment options are limited and management continues to be challenging. This discussion will address the potential utility of gonadotropin-releasing hormone agonists (GnRHa) in hyperandrogenic disorders. This form of treatment is an exciting advance because the use of GnRHa for the treatment of hirsutism is not duration-limited, in that the inevitable hypoestrogenism can be managed by concurrent estrogen replacement therapy. This is in contrast to using GnRHa to treat estrogen-dependent conditions such as endometriosis or uterine fibroids.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Andreyko JL, Marshall LA, Dumesic DA, Jaffe RB. Therapeutic uses of gonadotropin-releasing hormone analogs. Obstet Gynecol Surv 1987; 42: 1.
Friedman AJ, Barbieri RL. Leuprolide acetate: Applications in gynecology. Curr Probl Obstet Gynecol Fertil 1988; 11: 205.
Chang RJ, Laufer LR, Meldrum DR, DeFazio J, Lu JKH, Wylie WV, Rivier JE, Judd HL. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 1983; 56: 897.
Calogero AE, Macchi M, Montanini V, Mongioi A, Mauferi G, Vicari E, Coniglione F, Sipione C, D’Agata R. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone. J Clin Endocrinol Metab 1987; 64: 980.
Andreyko JL, Monroe SE, Jaffee RB. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin). J Clin Endocrinol Metab 1986; 63: 854.
Faure N, Lemay A. Ovarian suppression in polycystic ovarian disease during six-month administration of luteinizing-hormone releasing hormone (LH-RH) agonist. Clin Endocrinol (Oxf) 1987; 27: 703.
Faure N, Lemay A. Acute pituitary-ovarian response during chronic luteinizing hormone- releasing hormone agonist administration in polycystic ovarian syndrome. Clin Endocrinol (Oxf) 1988; 29: 403.
Steingold K, DeZiegler D, Cedars M, Meldrum DR, Lu JKH, Judd HL, Chang RJ. Clinical and hormonal effects of chronic gonadotropin- releasing hormone agonist treatment in polycystic ovarian disease. J Clin Endocrinol Metab 1987; 65: 773.
Couzinet B, Le Strat N, Brailly S, Schaison G. Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease. J Clin Endocrinol Metab 1986; 63: 103.
Schaison G, Couzinet B. Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease. Horm Res 1987; 28: 169.
Rittmaster RS. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide. J Clin Endocrinol Metab 1988; 67: 651.
Ceders MI, Steingold KA, de Ziegler D, Lapolt PS, Chang RJ, Judd HL. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction. Fertil Steril 1992; 57: 495.
Kennedy L, Traub AI, Atkinson AB, Sheridan B. Short-term administration of gonadotropin- releasing hormone analog to a patient with a testosterone-secreting ovarian tumor. J Clin Endocrinol Metab 1987; 64: 1320.
Parr JH, Abraham RR, Seed M, Short F, Wynn V. The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist. J Endocrinol Invest 1988; 11: 433.
Adashi EY. Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism. Fertil Steril 1990; 53: 765.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Adashi, E.Y. (1993). GnRH Agonists in the Treatment of Hyperandrogenism. In: Seibel, M.M., Bernstein, J. (eds) Technology and Infertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9205-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9205-7_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9207-1
Online ISBN: 978-1-4613-9205-7
eBook Packages: Springer Book Archive